Screener
Intellia Therapeutics NTLA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's total equity?
- Intellia Therapeutics (NTLA) reported total equity of $727.71M in Q2 2026.
- How has Intellia Therapeutics's total equity changed year-over-year?
- Intellia Therapeutics's total equity increased by 201.7% year-over-year, from -$715.26M to $727.71M.
- What is the long-term trend for Intellia Therapeutics's total equity?
- Over 5 years (2020 to 2025), Intellia Therapeutics's total equity has grown at a 5.0% compound annual growth rate (CAGR), from $527.07M to $671.39M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Intellia Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude